The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency (NEW 11/2, Website, Publication)Nature (Cellular & Molecular Immunology)
25 October 2021
Arora P, Rocha C, Kempf A, et al.
The novel coronavirus’ spike protein plays additional key role in illness (NEW 5/14, Website, News)The Salk Institute
30 April 2021
Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease